Last reviewed · How we verify

NCT07360886: NeuroDrive

Early Detection of Selected Neuropathologies in Motor Vehicle Drivers

Recruiting now Last updated 22 January 2026
What this trial tests

trial in Multiple Sclerosis in 200 participants. Currently enrolling.

Timeline
1 November 2025
Primary endpoint
31 December 2026
31 December 2028

Quick facts

Lead sponsorUniversity Hospital Olomouc
StatusRecruiting now
Study typeOBSERVATIONAL
Enrollment200
Start date1 November 2025
Primary completion31 December 2026
Estimated completion31 December 2028
Sites1 location across Czechia

Conditions studied

Sponsor

University Hospital Olomouc

Who can join

Adults 18 to 85, any sex, with Multiple Sclerosis or Parkinson Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aims to develop accessible methods for the early detection of selected neuropathologies in drivers, focusing on multiple sclerosis and Parkinson's disease. The primary objective is to identify clinical tests that correlate with outcomes from the Vienna Test System (VTS), thereby enabling early diagnosis without the need for complex neurological or neuropsychological assessments. Findings could improve the effectiveness of routine driver medical check-ups and inform future modifications to Czech traffic law to enhance road safety.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Multiple Sclerosis

Currently open trials in the same condition.

Other University Hospital Olomouc trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07360886.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing